V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160012819 | 160015505 | 1.63 | 68.8 | Palliative (P) | 2017-03-12 | 2017-04-02 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101236162 |
| 160012826 | 160015506 | 1.88 | 82.2 | Palliative (P) | null | 2022-01-21 | Vinorelbine (oral) | 01 | N | VINORELBINE | 100766426 |
| 160012827 | 160015507 | 1.7 | 87.7 | Palliative (P) | null | 2019-01-27 | Trabectedin | 02 | N | TRABECTEDIN | 100615569 |
| 160012829 | 160015508 | 1.67 | 76 | Palliative (P) | 2018-05-12 | 2018-05-12 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100713993 |
| 160012830 | 160015509 | 1.75 | 88.5 | Palliative (P) | 2019-02-14 | 2019-09-25 | Doxorubicin 75mg/m2 | 02 | N | TRIAL UNSPECIFIED | 101446183 |
| 160012834 | 160015510 | 1.84 | 85.3 | null | 2017-08-14 | 2017-08-14 | Trabectedin | 02 | null | TRABECTEDIN | 100180625 |
| 160012838 | 160015511 | 1.57 | 88 | null | null | 2020-10-20 | Doxorubicin 75mg/m2 | 02 | null | NIVOLUMAB | 100702533 |
| 160012846 | 160015512 | 1.82 | 80.8 | Palliative (P) | 2018-07-08 | 2018-08-06 | Trabectedin | null | N | TRABECTEDIN | 101422751 |
| 160012862 | 160015513 | 1.6 | 66.7 | Palliative (P) | 2018-12-11 | 2018-12-18 | Doxorubicin 75mg/m2 | null | N | TRIAL UNSPECIFIED | 101238666 |
| 160012865 | 160015514 | 1.72 | 48.4 | Palliative (P) | 2021-05-17 | 2021-07-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101439407 |
| 160012872 | 160015515 | 1.68 | 51 | Palliative (P) | 2017-10-19 | 2018-01-07 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100743013 |
| 160012878 | 160015516 | 1.72 | 81.4 | Palliative (P) | 2019-06-21 | 2020-08-17 | Doxorubicin 75mg/m2 | 02 | N | TRABECTEDIN | 101379210 |
| 160012880 | 160015517 | 1.54 | 61.6 | Palliative (P) | 2018-01-19 | 2018-01-20 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101734027 |
| 160012884 | 160015518 | null | 82.3 | Palliative (P) | 2020-11-04 | 2020-11-19 | VINORELBINE | 02 | N | VINORELBINE | 101005268 |
| 160012890 | 160015519 | 1.77 | 68.2 | Palliative (P) | 2018-11-04 | 2018-11-29 | DOXORUBICIN | null | null | DOXORUBICIN | 101580387 |
| 160012891 | 160015520 | 1.63 | 78.95 | Palliative (P) | 2017-11-20 | 2017-11-20 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101578003 |
| 160012900 | 160015521 | 1.6 | 79.6 | Palliative (P) | 2020-03-17 | 2020-09-14 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101816000 |
| 160012909 | 160015522 | 1.75 | 63 | null | 2018-07-27 | 2018-07-27 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100374174 |
| 160012912 | 160015523 | 1.75 | 78.1 | Palliative (P) | 2022-01-30 | 2022-02-04 | Trabectedin | 02 | null | TRABECTEDIN | 100371096 |
| 160012914 | 160015524 | 1.75 | 86.1 | null | 2019-03-10 | 2019-04-14 | Vinorelbine (oral) | 02 | null | VINORELBINE | 100701225 |
| 160012920 | 160015525 | 1.72 | 102.8 | Palliative (P) | 2020-08-29 | 2020-08-31 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101021910 |
| 160012927 | 160015526 | null | 96.8 | Palliative (P) | 2017-10-05 | 2020-02-25 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100064513 |
| 160012929 | 160015527 | 1.85 | 81.3 | Palliative (P) | 2022-04-18 | 2022-04-19 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100243657 |
| 160012932 | 160015528 | 1.9 | 71.3 | Palliative (P) | 2018-05-19 | 2018-05-27 | Vinorelbine IV | null | N | VINORELBINE | 101154151 |
| 160012933 | 160015529 | 1.75 | 60.5 | Palliative (P) | 2021-06-27 | 2021-06-30 | Doxorubicin 75mg/m2 | 02 | null | TRABECTEDIN | 101799509 |
| 160012935 | 160015530 | 1.74 | 91.4 | Palliative (P) | 2019-01-30 | 2019-02-07 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100915244 |
| 160012937 | 160015531 | 1.92 | 88.2 | null | 2019-10-15 | 2019-11-03 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100070628 |
| 160012938 | 160015532 | 1.73 | 73.5 | Palliative (P) | 2021-01-03 | 2021-07-11 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101347946 |
| 160012946 | 160015533 | 1.72 | 70 | Palliative (P) | 2018-09-27 | 2018-10-27 | DOXORUBICIN | 02 | N | VINORELBINE | 100973299 |
| 160012947 | 160015534 | 1.69 | 82.3 | Palliative (P) | 2021-10-11 | 2021-10-13 | DOXORUBICIN | 02 | N | TRABECTEDIN | 100117873 |
| 160012963 | 160015536 | 1.89 | 43.7 | null | 2019-07-29 | 2019-08-12 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100483159 |
| 160012964 | 160015537 | 1.62 | 50.6 | Palliative (P) | null | null | DOXORUBICIN | 02 | N | DOXORUBICIN | 100851834 |
| 160012969 | 160015538 | 1.62 | 84.8 | Palliative (P) | 2019-11-30 | 2019-12-06 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100337496 |
| 160012975 | 160015539 | 1.72 | 70.8 | null | 2018-12-10 | 2018-12-13 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100109967 |
| 160012980 | 160015540 | 1.85 | 60.1 | null | null | null | Vinorelbine (weekly iv) | 02 | null | VINORELBINE | 100985543 |
| 160012983 | 160015541 | 1.6 | 53.75 | null | 2021-05-15 | 2021-05-28 | Trabectedin | 02 | null | TRABECTEDIN | 100136543 |
| 160012992 | 160015542 | 1.62 | 55.6 | null | 2017-05-01 | 2017-05-20 | Trabectedin | N | null | TRABECTEDIN | 101354948 |
| 160012995 | 160015543 | 1.73 | 62.1 | null | 2018-11-24 | 2018-11-24 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100907122 |
| 160013000 | 160015544 | 1.67 | null | Palliative (P) | null | null | Doxorubicin 75mg/m2 | 02 | N | TRIAL UNSPECIFIED | 100624951 |
| 160013002 | 160015545 | 1.68 | 82 | Palliative (P) | 2019-11-26 | 2019-12-17 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101135082 |
| 160013009 | 160015546 | 1.75 | 65 | null | 2019-07-24 | 2019-07-24 | Doxorubin 50mg/m2 | 02 | null | VINORELBINE | 101850687 |
| 160013012 | 160015547 | 1.86 | 67.15 | Palliative (P) | 2019-04-24 | 2019-04-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101255066 |
| 160013014 | 160015548 | 1.82 | 90 | null | 2018-05-23 | 2018-06-17 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100398207 |
| 160013023 | 160015549 | 1.68 | 82.7 | Palliative (P) | 2019-01-26 | 2019-02-23 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100256736 |
| 160013026 | 160015550 | 1.82 | 107.3 | null | 2021-02-14 | 2021-02-20 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100784534 |
| 160013031 | 160015551 | 1.75 | 66.8 | null | 2021-09-16 | 2021-09-17 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101708657 |
| 160013038 | 160015552 | 1.61 | 72 | Neo-adjuvant (N) | 2019-05-06 | 2019-05-30 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101790813 |
| 160013039 | 160015553 | 1.64 | 60.55 | 03 | 2016-04-16 | 2016-07-24 | Doxorubicin 75mg/m2 | Y | N | DOXORUBICIN | 101266644 |
| 160013060 | 160015555 | 1.68 | 0 | null | null | 2017-08-21 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100263337 |
| 160013061 | 160015556 | 1.7 | 81.6 | null | 2021-05-26 | 2021-07-15 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101356523 |